title: Subjective effects of transdermal nicotine among nonsmokers.
abstract: The subjective experience of nicotine, which may be influenced by personality traits as well as environmental factors, may be important for understanding the factors associated with the initiation and maintenance of nicotine dependence. The present study examined the effects of 7 mg transdermal nicotine among a relatively large sample (n = 91; 44 women) of college-aged nonsmokers. Using a placebo controlled, double-blind, within-subjects design, nicotine's effects were examined at rest and again after participants completed a sustained attention task. Sex and personality factors (Behavioral Inhibition and Behavioral Approach; BIS/BAS Scales; Carver & White, 1994) were examined as potential moderators. Overall, the effects of nicotine were generally modest and unpleasant. In the context of the cognitive task, nicotine increased nausea and negative affect but reduced fatigue, relative to placebo. In contrast, effects of nicotine during the initial 4 hr of patch administration, in which participants were in their natural environments, were moderated by individual differences in behavioral approach. Neither behavioral inhibition nor gender reliably moderated any subjective effects of nicotine. The present work suggests transdermal nicotine exerts only modest, mostly negative effects among nonsmokers. Future work should examine both contextual and personality moderators in large samples of participants who are exposed to nicotine through multiple routes of administration.
authors.affiliation: Department of Psychology, University at Buffalo, USA.
authors.forename: Rebecca L
authors.initials: RL
authors.lastname: Ashare
authors.forename: Joseph S
authors.initials: JS
authors.lastname: Baschnagel
authors.forename: Larry W
authors.initials: LW
authors.lastname: Hawk
mesh_terms: D000279:Administration, Cutaneous; D000339:Affect / Q000187:drug effects*; D001288:Attention / Q000187:drug effects*; D003071:Cognition / Q000187:drug effects*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007206:Individuality; D008297:Male; D009325:Nausea / Q000139:chemically induced; D009538:Nicotine / Q000008:administration & dosage / Q000494:pharmacology*; D010551:Personality; D010919:Placebos; D011597:Psychomotor Performance / Q000187:drug effects; D012727:Sex Characteristics; D012907:Smoking / Q000523:psychology*; D055815:Young Adult
chemical_list: D010919:Placebos; D009538:Nicotine
references.citation: Drugs. 1993 Feb;45(2):157-70
references.pmid: 7681369
references.citation: Psychopharmacology (Berl). 1998 Jan;135(1):52-62
references.pmid: 9489934
references.citation: Exp Clin Psychopharmacol. 1999 Nov;7(4):454-63
references.pmid: 10609980
references.citation: Psychopharmacology (Berl). 1998 Nov;140(2):135-41
references.pmid: 9860103
references.citation: Drug Alcohol Depend. 2009 Jan 1;99(1-3):47-57
references.pmid: 18775605
references.citation: Psychopharmacology (Berl). 1997 Jun;131(4):361-70
references.pmid: 9226738
references.citation: Subst Use Misuse. 2003 Jan;38(1):67-83
references.pmid: 12602807
references.citation: Br J Soc Clin Psychol. 1978 Sep;17(3):269-73
references.pmid: 687883
references.citation: Natl Health Stat Report. 2009 May 20;(15):1-23
references.pmid: 19634304
references.citation: Addiction. 2004 Apr;99(4):472-81
references.pmid: 15049747
references.citation: Physiol Behav. 2002 Dec;77(4-5):683-7
references.pmid: 12527019
references.citation: J Abnorm Psychol. 2005 Feb;114(1):153-64
references.pmid: 15709822
references.citation: Nicotine Tob Res. 2008 Aug;10(8):1335-45
references.pmid: 18686181
references.citation: Addict Behav. 2008 Jan;33(1):106-21
references.pmid: 17913378
references.citation: MMWR Surveill Summ. 2008 Jun 6;57(4):1-131
references.pmid: 18528314
references.citation: Nicotine Tob Res. 2005 Jun;7(3):317-33
references.pmid: 16085500
references.citation: Behav Genet. 1995 Mar;25(2):119-32
references.pmid: 7733854
references.citation: Exp Clin Psychopharmacol. 1998 Feb;6(1):96-106
references.pmid: 9526150
references.citation: J Pers Soc Psychol. 1988 Jun;54(6):1063-70
references.pmid: 3397865
references.citation: Psychopharmacology (Berl). 2009 Sep;205(4):635-45
references.pmid: 19488740
references.citation: Psychopharmacology (Berl). 2002 Sep;163(2):194-201
references.pmid: 12202966
references.citation: Drug Alcohol Depend. 2000 May 1;59 Suppl 1:S61-81
references.pmid: 10773438
references.citation: Psychophysiology. 1989 May;26(3):311-20
references.pmid: 2756080
references.citation: Addiction. 1998 Apr;93(4):595-9
references.pmid: 9684398
references.citation: Behav Pharmacol. 1999 Nov;10(6-7):597-615
references.pmid: 10780501
references.citation: Exp Clin Psychopharmacol. 2000 Nov;8(4):462-71
references.pmid: 11127418
references.citation: Nicotine Tob Res. 2009 Sep;11(9):1055-66
references.pmid: 19633275
references.citation: J Clin Psychopharmacol. 1994 Aug;14(4):264-7
references.pmid: 7962682
references.citation: Psychol Bull. 2003 Mar;129(2):270-304
references.pmid: 12696841
references.citation: Nicotine Tob Res. 2002 Feb;4(1):25-70
references.pmid: 11906682
references.citation: MMWR Morb Mortal Wkly Rep. 2002 Jul 26;51(29):642-5
references.pmid: 12186222
references.citation: Psychopharmacology (Berl). 2001 May;155(2):163-70
references.pmid: 11401005
references.citation: J Consult Clin Psychol. 1993 Oct;61(5):723-31
references.pmid: 8245270